Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bluejay Diagnostics, Inc.

NASDAQ: BJDX · Industrial Applications and Services · 5 alerts · CIK 1704287

Share price
$2.29Close, Nov 16
Market cap
$2.56M
Shares outstanding
1.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bluejay Diagnostics, Inc. filings on SEC EDGAR ↗

9:04 AM ET 8-K
Clinical Trial Data

Bluejay Diagnostics Clinical Trial Data

Bluejay Diagnostics announced baseline clinical characteristics from its SYMON-II clinical validation study, which is evaluating the Symphony IL-6 Test for mortality risk in sepsis patients. The study includes 777 evaluable patients with an 18% mortality rate, providing a diverse dataset to support the company's planned regulatory submission. The data showed that non-survivors had higher baseline illness severity, with septic shock present in 56.4% of that group.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.